Vantage Health Announces Appointment of Joseph C. Peters,

New Post Public Reply Private Reply Replies (0) Message Board
Roger Wilco
Vantage Health Announces Appointment of Joseph C. Peters, Former White House Drug Policy Office’s Acting Deputy Director for State and Local Affairs under Presidents Clinton and Bush, to Its Board of Directors

bwlogo-106x27_044533.gif
http://finance.yahoo.com/news/vantage-health-...QA5NhXNyoA

Vantage Health Inc. (VNTH) ("Vantage Health" or the "Company" today announced the appointment of Joseph C. Peters to its Board of Directors, effective immediately. Mr. Peters will also serve as President of the company. Among other things, he will be involved in exploring possible applications of the Company’s technology to narcotics detection. Mr. Peters will replace departing board member Will Rees.

thumb_peters%20joseph.jpg

Mr. Peters, a Pennsylvania native, has throughout his career worked inside and outside of government to develop law enforcement and homeland security programs and technologies. An international expert in his field, Mr. Peters has participated in numerous conferences as principal or keynote speaker and has served as a television and radio commentator providing expert insight on law enforcement investigative and counter terrorism issues and technologies for numerous media outlets including CNN, FOX News Channel (NYC) and London’s Good Morning Television (GMTV).



Bringing 25 years of federal, state and local government experience, Mr. Peters served Presidents Clinton and Bush. He was involved in integrating technology into collaborative federal, state and local law enforcement operations, as the White House Drug Policy Office’s Acting Deputy Director for State and Local Affairs. This position included supervising the nation’s High Intensity Drug Trafficking Area (HIDTA) Program. Under Homeland Security Director Tom Ridge, Mr. Peters also served as the White House Drug Czar’s liaison to the White House Office of Homeland Security. Mr. Peters managed the country’s 26 HIDTA’s and their budget of a quarter of a billion dollars.

Early in his career as a Federal Prosecutor, Mr. Peters’ accomplishments included the conviction of a notorious crime boss and his mob enterprise. This trial, conducted by Mr. Peters and four other Federal Prosecutors, resulted in one of the most significant Mafia family convictions in United States history. As a result, Mr. Peters received the United States Department of Justice’s John Marshall Award. The Associated Press called Joseph Peters and his fellow prosecutors the “Modern Day Untouchables.”

Mr. Peters has earned a Juris Doctor from Dickinson School of Law, Carlisle PA and brings with him many noteworthy industry affiliations in drug enforcement, counterterrorism and law enforcement.

As the Company works to develop commercial applications of its technology, Mr. Peters’ deep-rooted experience and associations in law and drug enforcement will be invaluable.



About Vantage Health Inc.

Vantage Health Inc. - a mobile health technology company - is developing personalized and point-of-care screening using Apps based upon chemical sensing residing within a Bluetooth device that works with any smartphone. With its foundations in advanced nanotechnology, the company’s first product, the Vantage Health Sensor, which is in development, is the convergence of nano-electronics, bio-informatics, and wireless technology to create the next generation mobile health application. The first mobile App is expected to be for lung cancer screening with additional mobile healthcare Apps in the planning stages. The company has offices in Redwood City, CA and New York. For more information, please visit http://www.vantagehealthinc.com.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Vishay Intertechnology Announces Exciting Dividend Update

Updated Category News Views 130

Vishay Intertechnology's Quarterly Dividend Announcement Vishay Intertechnology, Inc. (NYSE: VSH), a global leader in the manufacturing of discrete semiconductors and passive components, has recently made headlines by declaring a quarterly dividend. This announcement marks a significant moment for the company and its stakeholders as it reflects the steady financial health...

Continue Reading
Why Energy Brokerage Is One of the Most Overlooked Recession-Resistant Service Models

Updated Category Economy Views 48

Most discussions about recession-resistant business categories focus on the obvious choices: healthcare, essential retail, waste management, and food. What rarely comes up, despite being one of the cleaner examples of a service with demand that genuinely does not shrink during economic downturns, is commercial energy management. Specifically, the energy brokerage model is...

Continue Reading
Stephens Ups Guaranty Bancshares Target to $40 with Positive Outlook

Updated Category News Views 51

Stephens Upgrades Guaranty Bancshares' Price Target Recently, Stephens announced an increase in its target price for Guaranty Bancshares, Inc. (NYSE: GNTY) to $40.00. This updated estimation is an advancement from the previous target of $38.00. The positive adjustment comes after the company reported strong third-quarter earnings per share (EPS), which exceeded analysts'...

Continue Reading
Lightwave Logic Prepares for Special Call on March 13, 2025

Updated Category News Views 113

Lightwave Logic's Upcoming Special Call Announcement Lightwave Logic, Inc. (NASDAQ: LWLG) has exciting news to share as it prepares to host a special call on March 13, 2025. This event aims to shed light on the industry applications of electro-optic polymers, the company’s competitive positioning, and its strategic approach to market penetration. What to Expect from the...

Continue Reading
Accelerating Oncology: ONCare Alliance and Ovation.io Team Up

Updated Category News Views 106

Innovative Partnership Between ONCare Alliance and Ovation.io The ONCare Alliance and Ovation.io have embarked on an exciting collaboration to develop a multi-omics database and biobank aimed at accelerating biomarker discovery in the oncology field. This partnership combines the expertise of 32 independent oncology practices represented by ONCare with Ovation.io, a...

Continue Reading